Numantec / News
News
With a focus on innovation and the strengthening of a sector that is constantly growing and evolving, NUMANTEC was established—a new biomedical group composed of various entities specialized in healthcare assistance solutions.
Numantec, a leading global developer, manufacturer and distributor of infusion medical devices, announced that the Private Equity business at Goldman...
Lower urinary tract disorders can affect men, women and children, significantly impacting their quality of life. Urinary incontinence, difficulty emptying...
When selecting a syringe, attention is often focused on capacity, delivery accuracy and ease of use. However, there is a...
In the day-to-day management of vascular access devices, even seemingly simple procedures such as catheter flushing can affect organisational efficiency...
Numantec at the 14th NIVAS Congress 2026: Innovation and International Exchange in Vascular Access
On 7 and 8 July 2026, the Numantec Group will take part in the 14th NIVAS Congress, one of the...
The Impact of Vascular Access on Patient Comfort
When discussing vascular access, attention often focuses on the technical aspects of the procedure, the duration of treatment or the...
The choice of a PICC certainly depends on the duration of therapy and the type of infusion required. However, its...
In haemodynamic monitoring, the quality of arterial access has a direct impact on the reliability of measurements and on the...
Although vascular access is one of the most frequently performed procedures in everyday clinical practice, insertion is not always simple...
